nivolumab,ipilimumab
bms
['breast', 'icon']
more on results from the icon-study for #breastcancer @ #esmo2022. published by published by 
Director, Institute for Cancer Research, Oslo University Hospital; Group Leader, Dept. of  Cancer Immunology, Professor Inst. Clin. Medicine, University of Oslo